brand

  • US most susceptible to brand erosion

    On average, small molecule brands in the US experienced the greatest degree of brand erosion following patent expiry and exposure to direct generic competition, according to a report from Datamonitor. Following the US, brand erosion was next most…

    brand | 01 March 2011

  • Slow growth for branded prescriptions

    Growth will slow to 1.3 percent in 2015 for the branded prescription pharmaceutical industry’s leading companies, according to Datamonitor. Between 2003 and 2009, theses same companies enjoyed robust sales growth at a compound annual growth rat…

    brand | 01 March 2011

  • Strategic realignment of brand portfolio

    The Bayer Group plans to greatly strengthen the "Bayer" umbrella brand and steadily reduce the number of its other corporate brands. "We have thoroughly analyzed our brand portfolio and found that the diversity of brands in the Bayer Group has dilute…

    brand | 16 November 2010

  • PharmaNet launches new brand identity

    PharmaNet Development Group, provider of global drug development services to the pharmaceutical, biotechnology, generics, and medical device industries, is launching a new brand identity and tagline, "PharmaNet Works For You". The new brand and tagl…

    brand | 01 November 2010

  • Porvair Filtration Group Increases Focus On Single Brand Identity

    Porvair Filtration Group has announced that its operating divisions - Porvair Technology, MF&T, Filters for Industry, Microfiltrex, and its US operation will increasingly focus on trading under a single corporate brand - Porvair Filtration Group. …

    brand | 12 May 2010

  • Branded Pharma Needs to Capitalize on Emerging Markets

    With US$110 billion in global sales exposed to generic competition for the top 50 pharmaceutical companies through to 2014, branded pharma must look to emerging markets, biologics and continued cost-saving initiatives to drive growth according to Dat…

    brand | 05 May 2010

  • Integra Biosciences Adopts New Corporate Brand

    Following its recent merger with the Viaflo Corporation, Integra Biosciences has announced that the companies will adopt the corporate brand – Integra, from January 1, 2010. Elmar Morscher, CEO of Integra Biosciences said, “The recent merger b…

    brand | 12 January 2010

  • Online Drug Brand Abuse Rises

    MarkMonitor has released its latest Brandjacking Index, which finds a parallel online system of pharmaceutical supply and demand fuelled by continued growth in listings for pharmaceuticals on business-to-business (B2B) exchange sites as well as incre…

    brand | 01 October 2009

  • Nycomed to Acquire Local Portfolio from Sanofi-Aventis and Zentiva

    Nycomed has agreed with Sanofi-Aventis and Zentiva to purchase 20 branded generic products in several Central and Eastern European countries. The agreement will strengthen the former’s market position especially in the Czech Republic and Slova…

    brand | 01 September 2009

  • UK Budget Heralds Price Cuts on Branded Pharmaceuticals

    As part of the UK government’s drive to save £2.3 billion (US$3.4 billion) in the National Health Service (NHS) during 2010–11, £550m will be cut from the prices of branded drugs as a result of the revised Pharmaceutical Price Regulation Schem…

    brand | 01 June 2009

Page 1 Next > Last >>